BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Philpott CD, Droege CA, Droege ME, Healy DP, Courter JD, Ernst NE, Harger NJ, Foertsch MJ, Winter JB, Carter KE, Van Fleet SL, Athota K, Mueller EW. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study. Pharmacotherapy 2019;39:1066-76. [PMID: 31549737 DOI: 10.1002/phar.2332] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Farrar JE, Mueller SW, Stevens V, Kiser TH, Taleb S, Reynolds PM. Correlation of antimicrobial fraction unbound and sieving coefficient in critically ill patients on continuous renal replacement therapy: a systematic review. Journal of Antimicrobial Chemotherapy 2022;77:310-9. [DOI: 10.1093/jac/dkab396] [Reference Citation Analysis]
2 Li L, Li X, Xia Y, Chu Y, Zhong H, Li J, Liang P, Bu Y, Zhao R, Liao Y, Yang P, Lu X, Jiang S. Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy. Front Pharmacol 2020;11:786. [PMID: 32547394 DOI: 10.3389/fphar.2020.00786] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
3 Jang SM, Lewis SJ, Mueller BA. Harmonizing antibiotic regimens with renal replacement therapy. Expert Review of Anti-infective Therapy 2020;18:887-95. [DOI: 10.1080/14787210.2020.1764845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Al-Shaer MH, Philpott CD, Droege CA, Courter JD, Healy DP, Droege ME, Ernst NE, Mueller EW, Peloquin CA. Cefepime Population Pharmacokinetics and Target Attainment in Critically Ill Patients on Continuous Renal Replacement Therapy. Antimicrob Agents Chemother 2021;65:e00144-21. [PMID: 33722885 DOI: 10.1128/AAC.00144-21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang Q, Liu J, Zhai C, Liu J, M.a B. Analysis of Related Factors of Early Mortality in Patients with Severe Renal Injury Treated with Continuous Venovenous Hemodialysis. Journal of Healthcare Engineering 2022;2022:1-6. [DOI: 10.1155/2022/7812788] [Reference Citation Analysis]
6 Pais GM, Chang J, Barreto EF, Stitt G, Downes KJ, Alshaer MH, Lesnicki E, Panchal V, Bruzzone M, Bumanglag AV, Burke SN, Scheetz MH. Clinical Pharmacokinetics and Pharmacodynamics of Cefepime. Clin Pharmacokinet 2022. [PMID: 35764774 DOI: 10.1007/s40262-022-01137-y] [Reference Citation Analysis]
7 Kobic E, Gill CM, Mochon AB, Nicolasora NP, Nicolau DP. Cefiderocol Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemodiafiltration. Open Forum Infect Dis 2021;8:ofab252. [PMID: 34250190 DOI: 10.1093/ofid/ofab252] [Reference Citation Analysis]